Investing.com - Illumina reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Illumina announced earnings per share of $0.34 on revenue of $1.12B. Analysts polled by Investing.com EPS of $0.29 on revenue of $1.12B.
Illumina 's are up 18% and is trading at $199.97 , still down 50.48% from its 52 week high of $428.00 set on Wednesday, January 12, 2022.
Illumina shares lost 5.64% to trade at $199.97 in after-hours trade the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar